Skip to Main Content

Latest News

Common Questions About Antidepressants, Answered

Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to The New York Times about some common questions and misconceptions about antidepressants. Sanacora is director of the Yale Depression Research Program.

Source: The New York Times
Read more
  • Yale mental health experts weigh in on increasing national suicide rates

    In this article addressing data from the Centers for Disease Control and Prevention showing that the national suicide rate increased by 30 percent over the past two decades, Yale faculty including YCSC experts provide additional insight into this growing problem along with information about prevention efforts.

    Source: Yale Daily News
    Read more
  • Bipolar Disorder Patients Respond to Ketamine, Esketamine Treatment

    A small sample of patients with bipolar disorder displayed noteworthy improvement in their depressive symptoms after being treated with the rapid-acting antidepressant intravenous ketamine and the nasal spray esketamine, according to a new Yale led-study. Mia Santucci, BA, postgraduate associate, and Samuel Wilkinson, MD, associate professor of psychiatry, are lead and senior authors, respectively.

    Read more
  • People Are Injecting Ketamine at Home

    Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry, spoke to The Wall Street Journal about ketamine's effect on the brain and why it can work as an antidepressant.

    Source: The Wall Street Journal
    Read more
  • Depression — Understanding, Identifying, and Diagnosing

    Gerard Sanacora, MD, PhD, George D. and Esther S. Gross Professor of Psychiatry; and Sina Nikayin, MD, assistant professor of psychiatry, are featured in the first episode of a four-part Double Take video miniseries on depression from the New England Journal of Medicine.

    Source: The New England Journal of Medicine
    Read more
  • What I Want My Patients to Know: Ketamine for Depression

    Samuel Wilkinson, MD, associate professor of psychiatry and associate director of the Yale Depression Research Program, writes in Psychology Today about the history of ketamine, its use to treat depression, and how it compares to esketamine.

    Source: Psychology Today
    Read more
  • Searching Science for Life's Purpose

    Samuel T. Wilkinson, MD, associate professor of psychiatry, is author of the new book "Purpose: What Evolution And Human Nature Imply About the Meaning of Our Existence?"

    Read more
Get RSS Feed